Diagnosis and management of subclinical hypothyroidism in pregnancy

BMJ (Online)

Volumn 349, Issue , 2014, Pages

  Negro, Roberto ^a   Stagnaro Green, Alex ^b  

^a VITO FAZZI HOSPITAL   (Italy)

^b UNIVERSITY OF ILLINOIS AT URBANA CHAMPAIGN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LEVOTHYROXINE; THYROID PEROXIDASE ANTIBODY; THYROTROPIN; THYROXINE;

ADVERSE OUTCOME; AUTOIMMUNE THYROIDITIS; COHORT ANALYSIS; DISEASE ASSOCIATION; DRUG DOSE INCREASE; DRUG DOSE TITRATION; EUTHYROIDISM; FIRST TRIMESTER PREGNANCY; HORMONE SUBSTITUTION; HUMAN; IMMUNOASSAY; IODINE DEFICIENCY; LONGITUDINAL STUDY; MATERNAL HYPERTENSION; OBSERVATIONAL STUDY; PREGNANCY; PREGNANCY OUTCOME; PREMATURE LABOR; PREVALENCE; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL (TOPIC); RETROSPECTIVE STUDY; REVIEW; SPONTANEOUS ABORTION; SUBCLINICAL HYPOTHYROIDISM; THYROXINE BLOOD LEVEL; DOSE RESPONSE; DRUG ADMINISTRATION; FEMALE; GESTATIONAL AGE; HYPOTHYROIDISM; PREGNANCY COMPLICATIONS; PRENATAL CARE; PROCEDURES; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX; THYROID FUNCTION TEST; TREATMENT OUTCOME;

DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; FEMALE; GESTATIONAL AGE; HUMANS; HYPOTHYROIDISM; PREGNANCY; PREGNANCY COMPLICATIONS; PREGNANCY OUTCOME; PRENATAL CARE; PROSPECTIVE STUDIES; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX; THYROID FUNCTION TESTS; THYROXINE; TREATMENT OUTCOME;

EID: 84908582436     PISSN: 09598146     EISSN: 17561833     Source Type: Journal    
DOI: 10.1136/bmj.g4929     Document Type: Review

References (104)

1. Glinoer D. What happenstothe normal thyroid during pregnancy? Thyroid 1999;9:631-5.
2. Soldin OR Thyroid function testing in pregnancy and thyroid disease: trimester-specific reference intervals. Ther Drug Monit 2006;28:8-11.
3. Mandel SJ. Spencer CA. Hollowell JG. Are detection and treatment of thyroid insufficiency in pregnancy feasible? Thyroid 2005; 15:44-53.
4. Glinoer D. Riahi M. Griin JP, Kinthaert J. Risk of subclinical hypothyroidism in pregnant women with asymptomatic autoimmune thyroid disorders. J Clin Endocrinol Metab 1994;79:197-204.
5. Van den Boogaard E. Vissenberg R. Land JA. van Wely M. van der Post JA. Goddijn M. et al. Significance of (sub)clinicalthyroid dysfunction and thyroid autoimmunity before conception and in early pregnancy: a systematic review. Hum Reprod Update 2011;17:605-19.
6. Reid SM. Middleton R Cossich MC. Crowther CA. Bain E. Interventions for clinical and subclinical hypothyroidism pre-pregnancy and during pregnancy. Cochrane Database Syst Rev 2013;5:CD007752.
7. Thangaratinam S, Tan A, Knox E, Kilby MD, Franklyn J, Coomarasamy A. Association between thyroid autoantibodies and miscarriage and preterm birth: meta-analysis of evidence. BMJv 2011;342:d2616.
8. Stagnaro-Green A Abalovich M, Alexander E, Azizi F, Mestman J, Negro R, et al; American Thyroid Association Taskforce on Thyroid Disease During Pregnancy and Postpartum. Guidelines of the American Thyroid Association forthe diagnosis and management of thyroid disease during pregnancy and postpartum. Thyroid 2011;21:1081-125.
9. De Groot L, Abalovich M, Alexander EK, Amino N, Barbour L, Cobin RH, et al. Management of thyroid dysfunction during pregnancy and postpartum: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab 2012;97:2543-65.
10. Garber JR, Cobin RH, Gharib H, Hennessey JV, Klein I, Mechanick JI, et al; American Association of Clinical Endocrinologists and American Thyroid Association Taskforce on Hypothyroidism in Adults. Clinical practice guidelines for hypothyroidism in adults: cosponsored by the American Association of Clinical Endocrinologists and the American Thyroid Association. Endocr Pract 2012;18:988-1028.
11. Canaris GJ, Manowitz NR, Mayor G, Ridgway EC. The Colorado thyroid disease prevalence study. Arch Intern Med 2000;160:526-34.
12. Stricker R, Echenard M, Eberhart R, Chevailler MC, Perez V, Quinn FA, et al. Evaluation of maternal thyroid function during pregnancy: the importance of using gestational age-specific reference intervals. Eur J Endocrinol 2007;157:509-14.
13. Moleti M, Lo Presti VP, Campolo MC, Mattina F, Galletti M, Mandolfino M, et al. Iodine prophylaxis using iodized salt and risk of maternal thyroid failure in conditions of mild iodine deficiency. J Clin Endocrinol Metab 2008;93:2616-21.
14. Lockwood CM, Grenache DG, Gronowski AM. Serum human chorionic gonadotropin concentrations greater than 400000 IU/Lare invariably associated with suppressed serum thyrotropin concentrations. Thyroid 2009;19:863-8.
15. Zigman JM, Cohen SE, Garber JR. Impact of thyroxine-binding globulin on thyroid hormone economy during pregnancy. Thyroid 2003; 13:1169-75.
16. Roti E, Fang SL, Emerson CH, Braverman LE. Human placenta is an active site of thyroxine and 3, 3D, 5-triiodothyroninetyrosyl ringdeiodination. J Clin Endocrinol Metab 1981;53:498-501.
17. Dafnis E, Sabatini S. The effect of pregnancy on renal function: physiology and pathophysiology. Am J Med Sci 1992;303:184-205.
18. Soldin OR, Soldin D, Sastoque M. Gestation-specificthyroxine and thyroid stimulating hormone levels in the United States and worldwide. Ther Drug Monit 2007;29:553-9.
19. Yan YQ, Dong ZL, Dong L, Wang FR, Yang XM, Jin XY et al. Trimesterand method-specific reference intervals for thyroid tests in pregnant Chinese women: methodology, euthyroid definition and iodine statuscan influence the setting of reference intervals. Clin Endocrinol (Oxf) 2011;74:262-9.
20. Li C, Shan Z, Mao J, Wang W, Xie X, Zhou W, et al. Assessment of thyroid function during first-trimester pregnancy: what is the rational upper limit of serum TSH during the firsttrimester in Chinese pregnant women? J Clin Endocrinol Metab 2014;99:73-9.
21. Marwaha RK, Chopra S, Gopalakrishnan S, Sharma B, Kanwar RS, Sastry A, et al. Establishment of reference range for thyroid hormones in normal pregnant Indian women. BJOG 2008;115:602-6.
22. Korevaar TI, Medici M, de Rijke YB, Visser W, de Muinck Keizer-Schrama SM, Jaddoe VV, et al. Ethnic differences in maternal thyroid parameters during pregnancy: the generation R stud. J Clin Endocrinol Metab 2013;98:3678-86.
23. Kahric-Janicic N, Soldin SJ, Soldin OP, West T, Gu J, Jonklaas J. Tandem mass spectrometry improves the accuracy of free thyroxine measurements during pregnancy. Thyroid 2007;17:303-11.
24. Anckaert E, Poppe K, Van Uytfanghe K, Schiettecatte J, Foulon W, Thienpont LM. FT4 immunoassays maydisplaya pattern during pregnancysimilarto the equilibrium dialysis ID-LC/tandem MS candidate reference measurement procedure in spite of susceptibility towards binding protein alterations. Clin Chim Acta 2010;411:1348-53.
25. Dashe JS, Casey BM, Wells CE, Mclntire DD, Byrd EW, Leveno KJ, et al. Thyroidstimulating hormone in singleton and twin pregnancy: importance of gestational age-specific reference ranges. Obstet Gynecol 2005;106:753-7.
26. Lambert-Messerlian G, McClain M, Haddow JE, Palomaki GE, Canick JA, Cleary-Goldman J, et al; FaSTER Research Consortium. First- and second-trimester thyroid hormone reference data in pregnant women: a FaSTER (First-and Second-Trimester Evaluation of Risk for aneuploidy) Research Consortium study. Am J ObstetGynecol 2008;199:62.e1-6.
27. Cleary-Goldman J, Malone FD, Lambert-Messerlian G, Sullivan L, Canick J, Porter TF, et al. Maternal thyroid hypofunction and pregnancy outcome. ObstetGynecol 2008;112:85-92-
28. Haddow JE, McClain MR, Lambert-Messerlian G, Palomaki GE, Canick JA, Cleary-Goldman J, et al; First and Second Tri mester Evaluation of Risk for Fetal Aneuploidy Research Consortium. Variability in thyroid-stimulating hormone suppression by human chorionic gonadotropin during early pregnancy. J Clin Endocrinol Metab 2008;93:3341-7.
29. Bliddal S, Feldt-Rasmussen U, Boas M, Faber J, Juul A, Larsen T, et al. Gestational-age-specific reference ranges from different laboratories misclassify pregnantwomen's thyroid status: comparison of two longitudinal prospective cohort studies. Eur J Endocrinol 2013;170:329-39.
30. Allan WC, Haddow JE, Palomaki GE, Williams JR, Mitchell ML, Hermos RJ, et al. Maternal thyroid deficiency and pregnancy complications: implications for population screening. J Med Screen 2000;7:127-30.
31. Hollowell JG, Staehling NW, Flanders WD, Hannon WH, Gunter EW, Spencer CA et al. Serum TSH, T(4), and thyroid antibodies in the United States population (1988 to 1994): National Health and Nutrition Examination Survey (NHANES III). J Clin Endocrinol Metab 2002;87:489-99.
32. Unuane D, Velkeniers B, Anckaert E, Schiettecatte J, Tournaye H, Haentjens P, et al. Thyroglobulin antibodies: any added value in the detection of thyroid autoimmunity in women consulting for fertility treatment. Thyroid 2013;23:1022-8.
33. Krassas GE, Poppe K, Glinoer D. Thyroid function and human reproductive health. Endocr Rev 2010;31:702-55.
34. Casey BM, DasheJ S, Wells CE, Mclntire DD, Byrd W, Leveno KJ, et al. Subclinical hypothyroidism and pregnancy outcomes. Obstet Gynecol 2005;105:239-45.
35. Vaidya B, Anthony S, Bilous M, Shields B, Drury J, Hutchison S, et al. Detection of thyroid dysfunction in early pregnancy: universal screening ortargeted high-risk case finding? J Clin Endocrinol Metab 2007;92:203-7.
36. Männistö T, Vääräsmäki M, Pouta A, Hartikainen AL, Ruokonen A Surcel HM, et al. Perinatal outcome of children born to mothers with thyroid dysfunction or anti bodies: a prospective population-based cohort study. J Clin Endocrinol Metab 2009;94:772-9.
37. Blatt AJ, Nakamoto JM, Kaufman HW. National status of testing for hypothyroidism during pregnancy and postpartum. J Clin Endocrinol Metab 2012;97:777-84.
38. Moreno-Reyes R, Glinoer D, Van Oyen H, Vandevijvere S. High prevalence of thyroid disorders in pregnant women in a mildly iodine-deficient country: a population-based study. J Clin Endocrinol Metab 2013;98:3694-701.
39. Sahu MT, Das V, Mittal S, Agarwal A, Sahu M. Overt and subclinical thyroid dysfunction among Indian pregnant women and its effect on maternal and fetal outcome. Arch Gynecol Obstet 2010;281:215-20.
40. Aguayo A, Grau G, Vela A Aniel-Quiroga A, Espada M, Martul P, et al. Urinary iodine and thyroid function in a population of healthy pregnant women in the north of Spain. J Trace Element Med Biol 2013;27:302-6.
41. Andersson M, Karumbunathan V, Zimmermann MB. Global iodine status in 2011 and trendsoverthe past decade. J Nutr 2012;142:744-50.
42. Trumpff C, De Schepper J, Tafforeau J, Van Oyen H, Vanderfaeillie J, Vandevijvere S. Mild iodine deficiency in pregnancy in Europe and its consequences for cognitive and psychomotor development of children: a review. J Trace Element Med Biol 2013;27:174-83.
43. Bath SC, Steer CD, Golding J, Emmett P, Rayman MP. Effect of inadequate iodine status in UK pregnant women on cognitive outcomes in their children: results from the Avon Longitudinal Study of Parents and Children (ALSPAC). Lancet 2013;27:331-7.
44. Velasco I, Carreira M, Santiago P, Muela JA, García-Fuentes E, Sánchez-Muñoz B, et al. Effect of iodine prophylaxis during pregnancy on neurocognitive development of children during the first two years of life. J Clin Endocrinol Metab 2009;94:3234-41.
45. Caldwel KL, Makhmudov A, Ely E, Jones RL, Wang RY. lodine status of the US population, National Health and Nutrition Examination Survey, 2005-2006 and 2007-2008. Thyroid 2011;21:419-27.
46. Food and Nutrition Board. Institute of Medicine. Dietary reference intakes. National Academy Press, 2006:320-7.
47. Stagnaro-Green A, Sullivan S, Pearce EN. Iodine supplementation during pregnancy and lactation. JAMA 2012;23:1-2.
48. Jones WS, Man EB. Thyroid function in human pregnancy. Premature deliveries and reproductive failures of pregnant women with low serum butanol-extractable iodines. Maternal serum TBG and TBPA capacities. Am J ObstetGynecol 1969;104:909-14.
49. Stagnaro-Green A. Overt hyperthyroidism and hypothyroidism during pregnancy. Clin Obstet Gynecol 2011;54:478-87.
50. Leung AS, Millar LK, Koonings PP, Montoro M, Mestman JH. Perinatal outcome in hypothyroid women. Obstet Gynecol 1993;81:349-53.
51. Kuppens SMI, Kooistra L, Carwford WS, Vader HL, Hasaart THM, Oei SG, et al. Maternal thyroid function during gestation is related to breech presentation aat term. Clin Endocrinol 2010;72:820-4.
52. Männistö T, Vääräsmäki M, Pouta A, Hartikainen AL, Ruokonen A, Surcel HM, et al. Thyroid dysfunction and autoanti bodies during pregnancy as predictive factors of pregnancy complications and maternal morbidity in later life. J Clin Endocrinol Metab 2010;95:1084-94.
53. Negro R, Schwartz A, Gismondi R, Tinelli A, Mangieri T, Stagnaro-Green A. Increased pregnancy loss rate in thyroid antibody negative women with TSH levels between 2.5 and 5.0 in the first trimester of pregnancy. J Clin Endocrinol Metab 2010;95:E44-8.
54. Goel P, Kaur J, Sana PK, Tandon R, Devi L. Prevalence, associated risk factors and effects of hypothyroidism in pregnancy: a study from north India. Gynecol Obstet Invest 2012;74:89-94.
55. Su PY, Huang K, Hao JH, Xu YQ, Yan SQ, Li T, et al. Maternal thyroid function in the firsttwenty weeks of pregnancy and subsequent fetal and infant development: a prospective population-based cohort study in China. J Clin Endocrinol Metab 2011;96:3234-41.
56. Wilson KL, Casey BM, Mclntire DD, Halvorson LM, Cunningham FG. Subclinical thyroid disease and the incidence of hypertension in pregnancy. Obstet Gynecol 2012;119:315-20.
57. Tudela CM, Casey BM, Mclntire DD, Cunningham FG. Relationship of subclinical thyroid disease to the incidence of gestational diabetes mellitus. Obstet Gynecol 2012;119:983-8.
58. Schneuer FJ, Nassar N, Tasevski V, Morris JM, Roberts CL. Association and predictive accuracy of high TSH serum levels in first trimester and adverse pregnancy outcomes. J Clin Endocrinol Metab 2012;97:3115-22.
59. Karakosta P, Alegakis D, Georgiou V, Roumeliotaki T, Fthenou E, Vassilaki M, et al. Thyroid dysfunction and autoantibodies in early pregnancy are associated with increased risk of gestational diabetes and adverse birth outcomes. J Clin Endocrinol Metab 2012;97:4464-72.
60. Korevaar TI, Schalekamp-Timmermans S, de Rijke YB, Visser WE, Visser W, de Muinck Keizer-Schrama SM, et al. Hypothyroxinemia and TPO-antibody positivity are risk factors for premature delivery: the generation R study J Clin Endocrinol Metab 2013;98:4382-90.
61. Stagnaro-Green A, Chen X, Bogden J D, Davies TF, Scholl TO. The thyroid and pregnancy: a novel risk factor for very preterm delivery. Thyroid 2005;15:351-7.
62. Tierney K, Delpachitra P, Grossmann M, Onwude J, Sikaris K, Wallace EM, et al. Thyroid function and autoantibody status among women who spontaneously deliver under 35 weeks of gestation. Clin Endocrinol (Oxf) 2009;71:892-5.
63. Ashoor G, Maiz N, Rotas M, Jawdat F, Nicolaides KH. Maternal thyroid function at 11-13 weeks of gestation and spontaneous preterm delivery. O bstet Gynecol 2011;17:293-S.
64. Karagiannis G, Ashoor G, Maiz N, Jawdat F, Nicolaides KH. Maternal thyroid function at eleven to thirteen weeks of gestation and subsequent delivery of small for gestational age neonates. Thyroid 2011;21:1127-31.
65. Kharb S, Sardana D, Nanda S. Correlation of thyroid function with severity and outcome of pregnancy. Ann Med Health Sci Res 2013;3:43-6.
66. Negro R, Schwartz A, Gismondi R, Tinelli A, Mangieri T, Stagnaro-Green A. Universal screening versus case finding for detection and treatment of thyroid hormonal dysfunction during pregnancy. J Clin Endocrinol Metab 2010;95:1699-707.
67. Escobar GM, Obregon MJ, Rey FE. Clinical perspective: is neuropsycholgical development related to maternal hypothyroidism or to maternal hypothyroxinemia? J Clin Endocrinol Metab 2000;85:3975-87.
68. Haddow JE, Palomaki GE, Allan WC, Williams JR, Knight GJ, Gagnon J, et al. Maternal thyroid deficiency during pregnancy and subsequent neuropsychological development of the child. N Engl J Med 1999;341:549-55.
69. Smit BJ, Kok JH, Vulsma T, Briet JM, Wiersinga WM. Neurologic development of the newborn and young child in relation to maternal thyroid function. Acta Paediatr 2000;89:291-5.
70. Li Y, Shan Z, Teng W, Yu X, Fan C, Teng X, et al. Abnormalities of maternal thyroid function during pregnancy affect neuropsychological development of their children at 25-30 months. Clin Endocrinol2010;72:825-9.
71. Lazarus JH, Bestwick JP, Channon S, Paradice R, Maina A, Rees R, et al. Antenatal thyroid screening and childhood function. N Engl J Med 2012;366:493-501.
72. Männistö T, Mendola P, Grewal J, Xie Y, Chen Z, Laughon SK. Thyroid diseases and adverse pregnancy outcomes in a contemporary US cohort. J Clin Endocrinol Metab 2013;98:2725-33.
73. Männistö T, Mendola P, Reddy U, Laughon SK. Neonatal outcomes and birth weight in pregnancies complicated by maternal thyroid disease. Am J Epidemiol 2013;178:731-40.
74. Benhadi N, Wiersinga WM, Reitsma JB, Vrijkotte TG, Bonsel GJ. Higher maternal TSH levels in pregnancy are associated with increased risk for miscarriage, fetal or neonatal death. Eur J Endocrinol 2009;160:985-91.
75. Abalovich M, Gutierrez S, Alcaraz G, Maccallini G, Garcia A, Levalle O. Overt and subclinical hypothyroidism complicating pregnancy. Thyroid 2002;12:636-8.
76. Wikner BN, Sparre LS, Stiller CO, Kallen B, Asker C. Maternal use of thyroid hormones in pregnancy and neonatal outcome. Acta Obstet Gynecol 2008;87:617-27.
77. Nelson DB, Casey BM, McIntire DD, Cunningham FG. Subsequent pregnancy outcomes in women previously diagnosed with subclinical hypothyroidism. Am J Perinatol 2014;31:77-84.
78. American College of Obstetrics and Gynecology. ACOG practice bulletin. Thyroid disease in pregnancy. Number 37. Int J Gynaecol Obstet 2002;79:171-80.
79. Yu X, Chen Y, Shan Z, Teng W, Li C, Zhou W et al. The pattern of thyroid function of subclinical hypothyroid women with levothyroxine treatment during pregnancy. Endocrine 2013;44:710-5.
80. Abalovich M, Vazquez A, Alcaraz G, Kitagrodsky A, Szuman G, Calabrese C, et al. Adequate levothyroxine doses for the treatment of hypothyroidism newly discovered during pregnancy. Thyroid 2013;23:1478-83.
81. Mandel SJ, Larsen PR, Seely EW, Brent GA Increased need for thyroxine during pregnancy in women with primary hypothyroidism. N Engl J Med 1990;323:91-6.
82. Alexander EK, Marqusee E, Lawrence J, Jarolim P, Fischer GA, Larsen PR. Timing and magnitude of increases in levothyroxine requirements during pregnancy in women with hypothyroidism. N Engl J Med 2004;351: 241-9.
83. Kothari A, Gilring J. Hypothyroidism in pregnancy: pre-pregnancy thyroid status influences gestational thyroxine requirements. BJOG 2008;115:1704-8.
84. Abalovich M, Alcaraz G, Kleiman-Rubinsztein J, Pavlone MM, Conrelio C, Levalle O, et al. The relationship of preconception thyrotropin levels to requirements for increasing the levothyroxine dose during pregnancy in women with primary hypothyroid ism. Thyroid 2010;20:1175-8.
85. Yassa L, Marqusee E, Fawcett R, Alexander E. Thyroid hormone early adjustment in pregnancy (the THERAPY trial). J Clin Endocrinol Metabol 2010;95:3234-41.
86. Shields BM, Knight BA, Hill AV, Hattersley AT, Vaidya B. Five-year follow-up for women with subclinical hypothyroidism in pregnancy J Clin Endocrinol Metab2013;98: E1941-5.
87. Burch HB, Burman KD, Cooper DS, Hennessey JV. 2013 A survey of clinical practice patterns in the management of primary hypothyroidism. J Clin Endocrinol Metab 2014;99:2077-85.
88. Hallengren B, Lantz M, Andreasson B, Grennert L. Pregnant women on thyroxine substitution are often dysregulated in early pregnancy. Thyroid 2009;19:391-4.
89. Vadiveloo T, Mires GJ, Donnan PT, Leese GP. Thyroid testing in pregnant women with thyroid dysfunction in Tayside, Scotland: the thyroid epidemiology, audit and research study (TEARS). Clin Endocrinol (Oxf) 2013;78:466-71.
90. Garber JR, Cobin RH, Gharib H, Hennessey JV, Klein I, Mechanick JI, et al; American Association of Clinical Endocrinologists and American Thyroid Association Taskforce on Hypothyroidism in Adults. Clinical practice guidelines for hypothyroidism in adults: cosponsored by the American Association of Clinical Endocrinologists and the American Thyroid Association. Endocr Pract 2012;18:988-1028.
91. Reid SM, Middleton P, Cossich MC, Crowther CA, Bain E. Interventions for clinical and subclinical hypothyroidism pre-pregnancy and during pregnancy. Cochrane Database Syst Rev 2013;5;CD007752.
92. Gyamfi Bannerman C. Basic science and clinical evidence regarding treatment of subclinical hypothyroidism during pregnancy. Clin Obstet Gynecol 2011;54:488-92.
93. Wang W, Teng W, Shan Z, Wang S, Li J, Zhu L, et al. The prevalence of thyroid disorders during early pregnancy in China: the benefits of universal screening in the first trimester of pregnancy. Eur J Endocrinol 2011;164:263-8.
94. Horacek J, Spitalnikova S, Dlabalova B, Malirova E, Vizda J, Svilias I, et al. Universal screening detects two-times more thyroid disorders in early pregnancy than targeted high-risk case finding. Eur J Endocrinol 2010;163:645-50.
95. Vaidya B, Anthony S, Bilous M, Shields B, Drury J, Hutchison S, et al. Detection of thyroid dysfunction in early pregnancy: universal screening or targeted high-risk case finding? J Clin Endocrinol Metab 2007;92:203-7.
96. Haymart MR The role of clinical guidelines in patient care: thyroid hormone replacement in women of reproductive age. Thyroid 2010;20:301-7.
97. Rinaldi MD, Stagnaro-Green AS. Thyroid disease and pregnancy: degrees of knowledge. Thyroid 2007;17:747-53.
98. Potlukova E, Potluka O, Jiskra J, Limanova Z, Telicka Z, Bartakova J, et al. Is age a risk factor for hypothyroid ism in pregnancy? An analysis of 5223 pregnant women. J Clin Endocrinol Metab 2012;97:1945-52.
99. Vaidya B, Hubalewska-Dydejczyk A, Laurberg P, Negro R, Vermiglio F, Poppe K. Treatment and screening of hypothyroidism in pregnancy: results of a European survey. Eur J Endocrinol2012;166:49-54.
100. Chang DL, Leung AM, Braverman LE, Pearce EN. Thyroid testing during pregnancy at an academic Boston Area Medical Center. J Clin Endocrinol Metab2011;96: E1452-6.
101. Laurberg P, Andersen SL, Pedersen IB, Andersen S, Carlé A. Screening for overt thyroid disease in early pregnancy may be preferable to searching for small aberrations in thyroid function tests. Clin Endocrinol (Oxf) 2013;79:297-304.
102. Stagnaro-Green A. Optimal care for the pregnant patient with thyroid disease. J Clin Endocrinol Metab 2012;97:2619-22.
103. Dosiou C, Barnes J, Schwartz A, Negro R, Crapo L, Stagnaro-Green A. Cost effectiveness for universal and risk-based screening for autoimmune thyroid disease in pregnant women. J Clin Endocrinol Metab 2012;97:334-42.
104. Teng W, Shan Z. Pregnancy and thyroid diseases in China. Thyroid 21:1053-5.